Outcome of recurrent and metastatic small cell carcinoma of the bladder

BMC Urology

Volumn 9, Issue 1, 2009, Pages

  Ismaili, Nabil ^a,b   Heudel, Pierre Etienne ^b   Elkarak, Fadi ^b   Kaikani, Wafaa ^a,b   Bajard, Agathe ^b   Ismaili, Mohammed ^c   Errihani, Hassan ^a   Droz, Jean Pierre ^b   Flechon, Aude ^b  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Morocco)

^b CENTRE LÉON BÉRARD   (France)

^c MOULAY ISMAIL UNIVERSITY   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; PLATINUM DERIVATIVE; TOPOTECAN; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ALGORITHM; ARTICLE; BLADDER CARCINOMA; BONE METASTASIS; BRAIN METASTASIS; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CYSTECTOMY; CYSTOSCOPY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIVER METASTASIS; LUNG METASTASIS; LUNG SMALL CELL CANCER; MALE; MEDIASTINUM METASTASIS; METASTASIS; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PROBABILITY; PROGNOSIS; RECTUM CANCER; RECURRENT CANCER; RETROPERITONEAL TUMOR; RETROSPECTIVE STUDY; SMALL CELL CARCINOMA; SURVIVAL RATE; TRANSURETHRAL RESECTION; BLADDER TUMOR; COMPARATIVE STUDY; FRANCE; INCIDENCE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; TIME; TUMOR RECURRENCE;

AGED; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 67650742296     PISSN: 14712490     EISSN: 14712490     Source Type: Journal    
DOI: 10.1186/1471-2490-9-4     Document Type: Article

References (34)

1. Surveillance, Epidemiology, and End Results (SEER). National Cancer Institute, DCCPS SRP, Branch CS, Program Public-Use Data (1973 2000), Released April based on the November 2002 submission http://www.seer.cancer.gov
2. Primary small cell carcinoma of the bladder: a report of 25 cases. S Holmang G Borghede SL Johansson, J Urol 1995 153 1820 1822 10.1016/S0022- 5347(01)67320-8 7752326
3. Small cell carcinoma of the urinary bladder. A clinicopathologic, morphologic, immunohistochemical and ultrastructural study of 18 cases. CEM Blomjous W Vos HJ De Voogt P van der Valk CJLM Meijer, Cancer 1989 64 1347 57 10.1002/1097-0142(19890915)64:6<1347::AID-CNCR2820640629>3.0.CO;2-Q 2548704
4. Neurosecretory granules in small cell invasive carcinoma of the urinary bladder. SF Cramer M Aikawa M Cebelin, Cancer 1981 41 724 10.1002/1097- 0142(19810215)47:4<724::AID-CNCR2820470417>3.0.CO;2-2
5. Pathology and Genetics of Tumours of the Urinary System and Mal Genital Organs. WHO Classification of the Tumours, IARC Press Lon, France, Eble JN, Sauter G, Epstein J, 2004
6. Small cell cancer of the bladder: The Leon-Berard cancer centre experience. N Ismaili F Elkarak PE Heudel A Flechon JP Droz, Indian J Urol 2008 24 494 7 19468504 10.4103/0970-1591.44255
7. Chromosomal imbalances in small cell carcinomas of the urinary bladder. L Terracciano J Richter L Tornillo L Beffa PA Diener R Maurer TC Gasser H Moch MJ Mihatsch G Sauter, J Pathol 1999 189 2 230 5 10.1002/(SICI)1096-9896(199910) 189:2<230::AID-PATH407>3.0.CO;2-8 10547580
8. Small cell carcinoma of the genitourinary tract: an immunohistochemical, electron microscopic and clinicopathological study. ME Christopher AD Seftel K Sorenson MI Resnick, J Urol 1991 146 2 382 8 1713277
9. Cytology of small cell carcinoma of the urinary bladder. KH van Hoeven RL Artymyshyn, Diagn Cytopathol 1996 14 4 292 7 10.1002/(SICI)1097-0339(199605)14: 4<292::AID-DC3>3.0.CO;2-I 8725127
10. Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases. NA Abrahams C Moran AO Reyes A Siefker-Radtke AG Ayala, Histopathology 2005 46 1 57 63 10.1111/j.1365-2559.2004.01980.x 15656887
11. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases. DJ Grignon JY Ro AG Ayala DT Shum NG Ord̃ez CJ Logothetis DE Johnson B Mackay, Cancer 1992 69 2 527 36 10.1002/1097-0142(19920115)69: 2<527::AID-CNCR2820690241>3.0.CO;2-7 1309435
12. Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression. KA Iczkowski JH Shanks WC Allsbrook A Lopez-Beltran CG Pantazis TR Collins RW Wetherington DG Bostwick, Histopathology 1999 35 2 150 6 10.1046/j.1365-2559.1999.00715.x 10460660
13. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. TD Jones KM Kernek XJ Yang A Lopez-Beltran GT MacLennan JN Eble H Lin CX Pan M Tretiakova LA Baldridge L Cheng, Hum Pathol 2005 36 7 718 23 10.1016/j.humpath.2005.04.007 16084939
14. Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder. X Wang S Zhang GT MacLennan JN Eble A Lopez-Beltran XJ Yang CX Pan H Zhou R Montironi L Cheng, Clin Cancer Res 2007 13 3 953 7 10.1158/1078-0432.CCR-06-2167 17289890
15. c-kit Expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications. CX Pan XJ Yang A Lopez-Beltran GT MacLennan JN Eble MO Koch TD Jones H Lin K Nigro V Papavero M Tretiakova L Cheng, Mod Pathol 2005 18 3 320 3 10.1038/modpathol.3800318 15502806
16. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. SN Agoff LW Lamps AT Philip MB Amin RA Schmidt LD True AL Folpe, Mod Pathol 2000 13 3 238 42 10.1038/modpathol.3880044 10757334
17. Small cell carcinoma of the bladder: Long term outcome with integrated chemoradiation. C Lohrisch N Murray T Pickles L Sullivan, Cancer 1999 86 11 2346 52 10.1002/(SICI)1097-0142(19991201)86:11<2346::AID-CNCR24>33.0.CO;2-5 10590377
18. Small cell carcinoma of the urinary bladder. NWW Choong J Fernando Quevedo JS Kaur, Cancer 2005 103 1172 1178 10.1002/cncr.20903 15700264
19. Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern California experience. ML Quek PW Nichols J Yamzon S Daneshmand G Miranda J Cai S Groshen JP Stein DG Skinner, J Urol 2005 174 1 93 6 10.1097/01.ju.0000162085.20043.1f 15947585
20. Small cell carcinoma of the urinary bladder: aclinicopathologic analysis of 64 patients. L Cheng CX Pan XJ Yang A Lopez-Beltran GT MacLennan H Lin TM Kuzel V Papavero M Tretiakova K Nigro MO Koch JN Eble, Cancer 2004 101 957 962 10.1002/cncr.20456 15329903
21. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. A Bex JA Nieuwenhuijzen M Kerst F Pos H van Boven W Meinhardt S Horenblas, Urology 2005 65 2 295 9 10.1016/j.urology.2004.09.049 15708041
22. Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladder. A Bex R de Vries F Pos M Kerst S Horenblas, World J Urol 2009 27 1 101 6 10.1007/s00345-008-0304-x 18607595
23. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. AO Siefker-Radtke CP Dinney NA Abrahams C Moran Y Shen LL Pisters HB Grossman DA Swanson RE Millikan, J Urol 2004 172 2 481 4 10.1097/01.ju.0000132413.85866.fc 15247709
24. Small-cell carcinoma of the urinary bladder: diagnosis and management. CX Pan H Zhang PN Lara Jr L Cheng, Expert Rev Anticancer Ther 2006 6 12 1707 13 10.1586/14737140.6.12.1707 17181484
25. Small cell cancer of the bladder: pathology, diagnosis, treatment and prognosis. N Ismaili S Arifi A Flechon OE Mesbahi JY Blay JP Droz H Errihani, Bull Cancer 2009 19457759
26. Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. M Fukuoka K Furuse N Saijo Y Nishiwaki H Ikegami T Tamura M Shimoyama K Suemasu, J Natl Cancer Inst 1991 83 12 855 61 10.1093/jnci/83.12.855 1648142
27. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up. S Sundstrøm RM Bremnes S Kaasa U Aasebø R Hatlevoll R Dahle N Boye M Wang T Vigander J Vilsvik E Skovlund E Hannisdal S Aamdal, J Clin Oncol 2002 20 24 4665 72 10.1200/JCO.2002.12.111 12488411
28. Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. BJ Roth DH Johnson LH Einhorn LP Schacter NC Cherng HJ Cohen J Crawford JA Randolph JL Goodlow GO Broun, J Clin Oncol 1992 10 2 282 91 1310103
29. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. K Noda Y Nishiwaki M Kawahara S Negoro T Sugiura A Yokoyama M Fukuoka K Mori K Watanabe T Tamura S Yamamoto N Saijo, N Engl J Med 2002 346 2 85 91 10.1056/NEJMoa003034 11784874
30. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. N Hanna PA Bunn Jr C Langer L Einhorn T Guthrie Jr T Beck R Ansari P Ellis M Byrne M Morrison S Hariharan B Wang A Sandler, J Clin Oncol 2006 24 13 2038 43 10.1200/JCO.2005.04.8595 16648503
31. Small-cell lung cancer. DM Jackman BE Johnson, Lancet 2005 366 9494 1385 96 10.1016/S0140-6736(05)67569-1 16226617
32. Phase II study of imatinib in patients with small cell lung cancer. BE Johnson T Fischer B Fischer D Dunlop D Rischin S Silberman MO Kowalski D Sayles S Dimitrijevic C Fletcher J Hornick R Salgia T Le Chevalier, Clin Cancer Res 2003 9 16 Pt 1 5880 7 14676110
33. A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study. GK Dy AA Miller SJ Mandrekar MC Aubry RM Langdon Jr RF Morton SE Schild JR Jett AA Adjei, Ann Oncol 2005 16 11 1811 6 10.1093/annonc/mdi365 16087693
34. Irinotecan, carboplatin, and imatinib in untreated extensive-stage small-cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network. DR Spigel JD Hainsworth L Simons C Meng HA Burris 3rd DA Yardley R Grapski M Schreeder PV Mallidi FA Greco, J Thorac Oncol 2007 2 9 854 61 10.1097/JTO.0b013e31814617b7 17805064